NALOXONE HYDROCHLORIDE INJECTION

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-8022 to Cardinal Health, Inc. (CAGE 00E55) for the supply of one package of Naloxone Hydrochloride Injection, identified by NSN 6505016998878, at a total price of $956.28. The award was issued on July 18, 2026, with delivery required by July 20, 2026, to the designated military destination USS CHARLESTON LCS 18, FPO AP 96694. The contract term is FOB destination, placing full responsibility for transportation, risk, and timely delivery on the contractor, who must use the fastest traceable means and explicitly avoid parcel post. Packaging and labeling must include the basic contract number SPE2DX-25-D-8022, the delivery order number SPE2D9-26-F-7441, the NSN, and the CAGE code 00E55, though no specific packaging, preservation, or barcoding standards such as MIL-STD-129 are formally mandated in the provided documentation. The contractor is required to comply with DLA Procedural Notes C19 and C20 and the Vendor Shipping Module (VSM) for logistics execution. Payment will be processed through the Defense Finance and Accounting Service at P.O. Box 182317, Columbus, OH 43218-2317, using voucher-based systems supported by EDI, with the accounting identifier BX: 97X4930 5CBX 001 2620 S33189. The awarding contracting officer is Lisa Quinn, with administrative support provided by Michelle Pampel of DLA Troop Support. Cardinal Health, Inc. is certified as a small business, a small disadvantaged business, and a woman-owned small business, with affirmations made in accordance with federal requirements and subject to SAM.gov recertification. Inspection and acceptance occur at the destination, and the contractor certifies the accuracy of payment claims, assuming liability under the False Claims Act. No formal contract type is declared, but the fixed price and single delivery suggest a firm fixed price arrangement. The order contains no options, quantities beyond the one unit specified, or variation tolerance, and no